MedTrace Logo

Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma

NCT02963896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-11-15

No results posted yet for this study

Summary

Surgical removal of vestibular schwannoma causes acute vestibular symptoms, including postoperative vertigo and oscilopsia due to nystagmus. In general, the dominant symptom postoperatively is vertigo. Preoperative chemical vestibular ablation can reduce vestibular symptoms postoperatively.

Conditions

  • Vestibular Schwannoma

Interventions

DRUG

gentamicin

intratympanic application of gentamicin 2m/80mg - 3x application -0,5 ml

Sponsors & Collaborators

  • University Hospital, Motol

    lead OTHER

Principal Investigators

  • Zdeněk Čada, Ph.D. · Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine Charles University in Prague and Motol University Hospital, Postgraduate Medical School

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963896 on ClinicalTrials.gov